Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Ethical practices – pharma’s obligation

March 8, 2011 Research and Development, Sales and Marketing ethics, industry relations, industry reputation

Pharmaceutical companies are not charities, and neither is any other business, by definition. Capitalism as a recognised system has been …
Feature

Service Insight: Emerging markets – a business development task or extreme fishing?

March 7, 2011 Sales and Marketing Service Insight, Surelines Ltd, emerging markets

SERVICE INSIGHTEmerging markets, new business; call it what you will but invariably the responsibility for grasping this nettle falls to …
Feature

GSK adds former Merck CFO to board

March 7, 2011 Sales and Marketing GSK, GlaxoSmithKline, Judy Lewent, Stacey Cartwright, appointment, sales and marketing

GlaxoSmithKline has appointed Judy Lewent to its board as a non-executive director. She has previously served as an executive VP …
Appointment

Eisai prepares ground for Halaven’s European launch

March 7, 2011 Sales and Marketing Cancer, EMBRACE, Eisai, Halaven, advanced breast cancer, breast cancer, eribulin

Eisai has published further details of a phase III trial of its first-in-class chemotherapy drug Halaven ahead of its hoped-for …
News

Eisai to cut 900 jobs ahead of Aricept patent loss

March 7, 2011 Sales and Marketing Aricept, Eisai, donepezil, generics, job cuts

Eisai is to cut around 900 jobs in Europe, the US and Japan over the next five years as it …
News
Novo Nordisk's Victoza

Novo’s Victoza beats Bydureon in head-to-head trial

March 4, 2011 Research and Development, Sales and Marketing Alkermes, Amylin, Byureon, Victoza, diabetes, exenatide, lilly, type II diabetes

Bydureon has been outperformed by rival Victoza in a head-to-trial, decimating shares in its co-developer Amylin and Alkermes, the company …
News

Onglyza expands European licence

March 4, 2011 Sales and Marketing AZ, AstraZeneca, BMS, Bristol-Myers Squibb, Onglyza, diabetes, renal impairment, saxagliptin, type II diabetes

European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …
News

First idiopathic pulmonary fibrosis drug approved

March 4, 2011 Sales and Marketing Esbriet, IPF, InterMune, Orphan Drugs, idiopathic pulmonary fibrosis, orphan drug

The first ever treatment for the potentially fatal lung disease idiopathic pulmonary fibrosis (IPF) has been approved in the EU. …
News
Sanofi's VTE avatar

Digital Pharma: online campaign directory updated

March 4, 2011 Medical Communications, Sales and Marketing Digital Pharma blog, Novartis, Pfizer, Sanofi-Aventis, VTE, diabetes, erectile dysfunction, pharmacist educaiton, venous thromboembolism, viagra

The latest update to the Digital Pharma links directory covers its online campaigns section and includes a pharmacist networking portal …
Feature

NICE rejects Lucentis for diabetic oedema

March 4, 2011 Sales and Marketing Lucentis, NICE, Novartis, VEGF, Vascular Endothelial Growth Factor, diabetic oedema, raibizumab

NICE’s draft guidance has not recommended Lucentis for diabetic oedema after ‘faulty analysis’ from manufacturer Novartis was found not to …
News
Blog footer

Digital Pharma: European doctors’ communities collaborate

March 3, 2011 Medical Communications, Sales and Marketing Coliquio, Digital Pharma blog, Doctors.net.uk, online doctors communities

Two of Europe’s leading medical professional communities have signed a strategic alliance that will see them collaborate on multi-market digital …
News
quintiles_jim_mcdermott

Jim McDermott to lead Quintiles Market Intelligence

March 3, 2011 Sales and Marketing Jim McDermott, Quintiles, appointment, sales and marketing

Quintiles has appointed Jim McDermott as managing director of the Market Intelligence practice within its Consulting group. The practice provides …
Appointment
GlaxoSmithKline's London headquarters

GSK to reimburse tuition fees for UK trainees

March 3, 2011 Business Services, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, UK science, careers, graduate, graduate recruitment

GlaxoSmithKline is set to reimburse UK university tuition fees paid by its trainees from 2012. Each year, GSK recruits between …
News

Forest’s COPD drug approved in US

March 3, 2011 Sales and Marketing COPD, Daliresp, Daxas, Forest, Forest Laboratories, chronic obstructive pulmonary disease, roflumilast

Daliresp (roflumilast) has been approved by the FDA to treat severe chronic obstructive pulmonary disease. Forest Laboratories’ once-daily pill is …
News
EMD Serono headquarters

FDA knocks back Merck KGaA’s oral MS drug

March 2, 2011 Sales and Marketing Cladribine, EMD Serono, FDA, MS, Merck KGaA, Movectro, multiple sclerosis, oral MS drugs

US authorities have turned down Merck KGaA’s new drug application for its oral relapsing-remitting multiple sclerosis treatment Movectro. The FDA …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026